These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23199366)

  • 1. Assessment of immunotoxicity using precision-cut tissue slices.
    Sewald K; Braun A
    Xenobiotica; 2013 Jan; 43(1):84-97. PubMed ID: 23199366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotoxicology; current developments and trends].
    Claassen E
    Ned Tijdschr Geneeskd; 1991 May; 135(20):879-85. PubMed ID: 2046788
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotoxicology: role in the safety assessment of drugs.
    Descotes J
    Drug Saf; 2005; 28(2):127-36. PubMed ID: 15691223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies.
    Morin JP; Baste JM; Gay A; Crochemore C; Corbière C; Monteil C
    Xenobiotica; 2013 Jan; 43(1):63-72. PubMed ID: 23030793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxicology and its application in risk assessment.
    Rooney AA; Luebke RW; Selgrade MK; Germolec DR
    Exp Suppl; 2012; 101():251-87. PubMed ID: 22945572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxic effects of chemicals: A matrix for occupational and environmental epidemiological studies.
    Veraldi A; Costantini AS; Bolejack V; Miligi L; Vineis P; van Loveren H
    Am J Ind Med; 2006 Dec; 49(12):1046-55. PubMed ID: 17036363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of immunotoxic effects of chemicals and assessment of their relevance to man.
    Trizio D; Basketter DA; Botham PA; Graepel PH; Lambré C; Magda SJ; Pal TM; Riley AJ; Ronneberger H; Van Sittert NJ
    Food Chem Toxicol; 1988 Jun; 26(6):527-39. PubMed ID: 3049276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of immunotoxicity: from animal studies to human biomonitoring.
    Van Loveren H; Steerenberg PA; Vos JG
    Toxicol Lett; 1995 May; 77(1-3):73-80. PubMed ID: 7618171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of immunotoxicity in safety assessment: a medical toxicologist's perspective.
    Descotes J
    Toxicol Lett; 2004 Apr; 149(1-3):103-8. PubMed ID: 15093254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS).
    Lauenstein L; Switalla S; Prenzler F; Seehase S; Pfennig O; Förster C; Fieguth H; Braun A; Sewald K
    Toxicol In Vitro; 2014 Jun; 28(4):588-99. PubMed ID: 24412833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of xenobiotics for direct immunotoxicity in an animal study.
    De Jong WH; Van Loveren H
    Methods; 2007 Jan; 41(1):3-8. PubMed ID: 17161297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotoxicology: opportunities for non-animal test development.
    Corsini E; Roggen EL
    Altern Lab Anim; 2009 Sep; 37(4):387-97. PubMed ID: 19807211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of immunotoxicology and current applications to respiratory diseases.
    Luster MI; Simeonova P; Gallucci R; Matheson J; Yucesoy B; Sugawara T
    Immunopharmacology; 2000 Jul; 48(3):311-3. PubMed ID: 10960674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotoxicology: review of current status.
    Luster MI; Germolec DR; Rosenthal GJ
    Ann Allergy; 1990 May; 64(5):427-32. PubMed ID: 2186671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of cytochrome P450 and phase II enzymes by xenobiotics in precision-cut tissue slices.
    Ioannides C
    Xenobiotica; 2013 Jan; 43(1):15-28. PubMed ID: 22742738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxicity testing using human primary leukocytes: An adjunct approach for the evaluation of human risk.
    Phadnis-Moghe AS; Kaminski NE
    Curr Opin Toxicol; 2017 Apr; 3():25-29. PubMed ID: 29619412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.
    DeWitt JC; Germolec DR; Luebke RW; Johnson VJ
    Curr Protoc Toxicol; 2016 Feb; 67(1):18.1.1-18.1.22. PubMed ID: 26828330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods of evaluating immunotoxicity.
    Descotes J
    Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):249-59. PubMed ID: 16866611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.